Beyond RCHOP: A Blueprint for Diffuse Large B Cell Lymphoma Research.
about
Recent advances in clinical studies and the evolving role of subtyping for patients with diffuse large B-cell lymphoma.Targeting the anion exchanger 2 with specific peptides as a new therapeutic approach in B lymphoid neoplasms.General Biomarker Recommendations for Lymphoma.Rapid, real time pathology review for ECOG/ACRIN 1412: a novel and successful paradigm for future lymphoma clinical trials in the precision medicine era.Time to treatment is an independent prognostic factor in aggressive non-Hodgkin lymphomas.Past, Present, and Future of Rituximab-The World's First Oncology Monoclonal Antibody Therapy.
P2860
Beyond RCHOP: A Blueprint for Diffuse Large B Cell Lymphoma Research.
description
2016 nî lūn-bûn
@nan
2016 թուականի Դեկտեմբերին հրատարակուած գիտական յօդուած
@hyw
2016 թվականի դեկտեմբերին հրատարակված գիտական հոդված
@hy
2016年の論文
@ja
2016年論文
@yue
2016年論文
@zh-hant
2016年論文
@zh-hk
2016年論文
@zh-mo
2016年論文
@zh-tw
2016年论文
@wuu
name
Beyond RCHOP: A Blueprint for Diffuse Large B Cell Lymphoma Research.
@ast
Beyond RCHOP: A Blueprint for Diffuse Large B Cell Lymphoma Research.
@en
type
label
Beyond RCHOP: A Blueprint for Diffuse Large B Cell Lymphoma Research.
@ast
Beyond RCHOP: A Blueprint for Diffuse Large B Cell Lymphoma Research.
@en
prefLabel
Beyond RCHOP: A Blueprint for Diffuse Large B Cell Lymphoma Research.
@ast
Beyond RCHOP: A Blueprint for Diffuse Large B Cell Lymphoma Research.
@en
P2093
P2860
P356
P1476
Beyond RCHOP: A Blueprint for Diffuse Large B Cell Lymphoma Research.
@en
P2093
Brad S Kahl
Grzegorz S Nowakowski
John P Leonard
Jonathan W Friedberg
Kristie A Blum
Laurie H Sehn
Lawrence Baizer
Michael E Williams
Richard F Little
Sonali M Smith
P2860
P356
10.1093/JNCI/DJW257
P407
P577
2016-12-16T00:00:00Z